Results 41 to 50 of about 25,239 (336)

Sex and Gender Considerations in Episodic Migraine

open access: yesCurrent Pain and Headache Reports, 2022
AbstractPurpose of ReviewWe seek to update readers on recent advances in our understanding of sex and gender in episodic migraine with a two part series. In part 1, we examine migraine epidemiology in the context of sex and gender, differences in symptomatology, and the influence of sex hormones on migraine pathophysiology (including CGRP).
Sarah R. Ahmad, Nicole Rosendale
openaire   +4 more sources

Functional Alterations in the Posterior Insula and Cerebellum in Migraine Without Aura: A Resting-State MRI Study

open access: yesFrontiers in Behavioral Neuroscience, 2020
Background: Hypothesis-driven functional connectivity (FC) analyses have revealed abnormal functional interaction of regions or networks involved in pain processing in episodic migraine patients.
Jun Ke   +17 more
doaj   +1 more source

A Controlled Trial of Erenumab for Episodic Migraine [PDF]

open access: yesNew England Journal of Medicine, 2017
We tested erenumab, a fully human monoclonal antibody that inhibits the calcitonin gene-related peptide receptor, for the prevention of episodic migraine.We randomly assigned patients to receive a subcutaneous injection of either erenumab, at a dose of 70 mg or 140 mg, or placebo monthly for 6 months.
Goadsby, Peter J.   +9 more
openaire   +5 more sources

Atogepant for the prevention of episodic migraine in adults

open access: yesSAGE Open Medicine, 2022
Objective: Atogepant is a newly approved medication for the prevention of migraine. This review aims to discuss the efficacy, safety, cost, and place in therapy of atogepant. Methods: The authors performed a systematic search for sources, including articles, abstracts, and poster presentations.
Maranda Paige Switzer   +3 more
openaire   +3 more sources

A Study to Assess the Effectiveness of Cold Pack Application on Episodic Pain Among Patients with Migraine in Selected Community Areas

open access: yesJournal of Pharmacy and Bioallied Sciences
Introduction: A migraine is typically described as a sick headache, since the patient apart from the headache feels very sick. Migraine is a genetic neurological disease, characterized by episodes often called Migraine attacks.
K Abinaya, Sharumathi
doaj   +1 more source

Thalamo-cortical network activity between migraine attacks. Insights from MRI-based microstructural and functional resting-state network correlation analysis [PDF]

open access: yes, 2016
BACKGROUND: Resting state magnetic resonance imaging allows studying functionally interconnected brain networks. Here we were aimed to verify functional connectivity between brain networks at rest and its relationship with thalamic microstructure in ...
Colonnese, Claudio   +11 more
core   +1 more source

Magnetic Suppression of Perceptual Accuracy Is Not Reduced in Visual Snow Syndrome

open access: yesFrontiers in Neurology, 2021
Objective: Patients with visual snow syndrome (VSS) suffer from continuous (“TV snow-like”) visual disturbance of unknown pathoetiology. In VSS, changes in cortical excitability in the primary visual cortex and the visual association cortex are discussed,
Ozan E. Eren   +6 more
doaj   +1 more source

Induction of chronic migraine phenotypes in a rat model after environmental irritant exposure [PDF]

open access: yes, 2017
Air pollution is linked to increased emergency department visits for headache and migraine patients frequently cite chemicals or odors as headache triggers, but the association between air pollutants and headache is not well understood.
Hurley, Joyce Harts   +4 more
core   +1 more source

Update on medication-overuse headache and its treatment [PDF]

open access: yes, 2015
OPINION STATEMENT: Medication-overuse headache-i.e., a too-frequent consumption of acute headache medications leading to increased headache frequency and reduced effectiveness of acute and preventive treatments-is a serious medical condition whose ...
Giamberardino MA   +2 more
core   +1 more source

Intravenous ketamine for subacute treatment of refractory chronic migraine: a case series. [PDF]

open access: yes, 2016
BACKGROUND: Refractory migraine is a challenging condition with great impact on health related quality of life. Intravenous (IV) ketamine has been previously used to treat various refractory pain conditions.
Ashina, Sait   +3 more
core   +3 more sources

Home - About - Disclaimer - Privacy